FdaApplication
NDA 203923
Identifiers
- fda_app_no: NDA203923
Properties
| Property | Value |
|---|---|
| applicant_name | HOPE PHARMACEUTICALS |
| application_type | NDA |
| approval_date | 2012-02-14 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SODIUM THIOSULFATE | SODIUM THIOSULFATE | 12.5GM/50ML (250MG/ML) | SOLUTION;INTRAVENOUS |
1 product